- Clinical Trial Update with Case Study Highlights
- Plans for Data Dissemination and Timelines
- Update on Advaxis’ Corporate Collaborations
- Research Update on the NEO and HOT Programs
- Progress Towards Regulatory Submission and Commercial Readiness
Watch this year’s Investor & Analyst Day in its entirety below: